JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

A8628 Chloroquine diphosphate
1 Citation

Target: Autophagy

Summary: Antimalarial drug,TLR7 TLR9 inhibitor

insoluble in DMSO; insoluble in EtOH; ≥106.06 mg/mL
A8629 DBeQ

Target: P97 ATPase

Summary: P97 ATPase inhibitor

≥16 mg/mL
A8630 Xanthohumol

Summary: VCP inhibitor

≥121.6 mg/mL
A8631 FK 866 hydrochloride

Target: NMPRTase

Summary: NMPRTase inhibitor

≥18.95 mg/mL
A8632 (±)-Bay K 8644

Summary: L-type Ca2+-channel activator

≥36.2 mg/mL
A8633 Concanamycin A
1 Citation

Target: Vacuolar-type ATPase

Summary: V-type (vacuolar) H+-ATPase inhibitor

soluble in DMSO
A8883 SAR405
22 Citation

Summary: Selective ATP-competitive inhibitor of Vps34

≥22.19 mg/mL
A8716 LY3009120

Target: Raf

Summary: pan-RAF and RAF dimer inhibitor

insoluble in H2O; insoluble in EtOH; ≥4.25 mg/mL
A8715 SBI-0206965
2 Citation

Target: ULK1

Summary: ULK1 inhibitor

≥24.47 mg/mL
B5873 Spautin-1
1 Citation

Target: Deubiquitinating enzymes (DUBs)|Autophagy

Summary: Novel autophagy inhibitor

insoluble in H2O; ≥13.5 mg/mL